- Home
- CYAB vs NCNA Comparison
CYAB vs NCNA Comparison
Compare CYAB & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CYAB | NCNA |
|---|---|---|
| Founded | 2017 | 1997 |
| Country | United States | United Kingdom |
| Employees | N/A | 12 |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0M | 9.7M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | CYAB | NCNA |
|---|---|---|
| Price | $0.68 | $2.32 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 459.2K | 36.7K |
| Earning Date | 04-09-2026 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.50 | $0.03 |
| 52 Week High | $2.99 | $10.00 |
Technical Indicators
Market Signals| Indicator | CYAB | NCNA |
|---|---|---|
| Relative Strength Index (RSI) | 33.12 | 59.61 |
| Support Level | $0.54 | $1.97 |
| Resistance Level | $1.65 | $2.28 |
| Average True Range (ATR) | 0.06 | 0.18 |
| MACD | 0.05 | 0.02 |
| Stochastic Oscillator | 67.93 | 80.36 |
Price Performance
Historical ComparisonAbout CYAB Cyabra Inc. Common Stock
Cyabra Inc is an AI-powered SaaS company that detects and analyzes online disinformation. Its platform uses machine learning to monitor social media and news data in real time, identify fake accounts and harmful narratives, and assess content authenticity and sentiment.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States and the United Kingdom.